Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manish Gautam

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
The Lancet. Oncology|December 5, 2024
Cancer research in South Asian Association for Regional Cooperation (SAARC) countriesM Saiful Huq, Sandhya C Acharya, Manish Gautam, et al.
NPJ Vaccines|February 21, 2024
A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL<sup>®</sup>) in infantsHitt Sharma, Sameer Parekh, Pramod Pujari, et al.
Eclinicalmedicine|December 6, 2021
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in IndiaPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Human Vaccines & Immunotherapeutics|March 21, 2024
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adultsPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
The European Respiratory Journal|December 24, 2021
A randomised controlled trial of intrapleural balloon intercostal chest drains to prevent drain displacementRachel M Mercer, Eleanor Mishra, Radhika Banka, et al.
American Journal of Respiratory and Critical Care Medicine|July 8, 2022
Human Infection Challenge with Serotype 3 PneumococcusRyan E Robinson, Elena Mitsi, Elissavet Nikolaou, et al.
The Lancet Regional Health. Southeast Asia|January 17, 2023
Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled studyPrasad S Kulkarni, Abhijit Kadam, Sheela Godbole, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
The Lancet. Oncology|December 5, 2024
Cancer research in South Asian Association for Regional Cooperation (SAARC) countriesM Saiful Huq, Sandhya C Acharya, Manish Gautam, et al.
NPJ Vaccines|February 21, 2024
A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL<sup>®</sup>) in infantsHitt Sharma, Sameer Parekh, Pramod Pujari, et al.
Eclinicalmedicine|December 6, 2021
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in IndiaPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
Human Vaccines & Immunotherapeutics|March 21, 2024
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adultsPrasad S Kulkarni, Chandrasekaran Padmapriyadarsini, Johan Vekemans, et al.
The European Respiratory Journal|December 24, 2021
A randomised controlled trial of intrapleural balloon intercostal chest drains to prevent drain displacementRachel M Mercer, Eleanor Mishra, Radhika Banka, et al.
American Journal of Respiratory and Critical Care Medicine|July 8, 2022
Human Infection Challenge with Serotype 3 PneumococcusRyan E Robinson, Elena Mitsi, Elissavet Nikolaou, et al.
The Lancet Regional Health. Southeast Asia|January 17, 2023
Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled studyPrasad S Kulkarni, Abhijit Kadam, Sheela Godbole, et al.
Pageof 8